Form 13F security
LAKEFRONT BIOTHERAPEUTICS NV
Class SPON ADR
As filed on Form 13F — long US-listed positions only. No shorts, cash, bonds, or non-13F assets appear here.
Filed up to 45 days after quarter end; holdings may have changed since.
Tracked managers holding it
Share and principal positions
| Manager | Quarter | Value | % of portfolio | SH/PRN qty | Put/call |
|---|---|---|---|---|---|
| DME Capital Management, LP — David Einhorn — Greenlight | 2026-06-30 | $14M | 0.4% | SH 482,746 | — |
| Point72 Asset Management, L.P. | 2026-06-30 | $8.1M | <0.1% | SH 269,814 | — |
Total $23M across 2 of 69 managers.
Sums are across tracked reports, not unique economic ownership.
DME Capital Management, LP — Combined report.
Filed rows (3) — as filed
The filer reports some securities in multiple rows; rows are shown as filed.
| Manager | Class | Put/call | Value | % of portfolio | SH/PRN qty | Source |
|---|---|---|---|---|---|---|
| DME Capital Management, LP | SPON ADR | — | $11M | 0.3% | SH 376,063 | 0001172661-26-003786 |
| Point72 Asset Management, L.P. | SPON ADR | — | $8.1M | <0.1% | SH 269,814 | 0000919574-26-005520 |
| DME Capital Management, LP | SPON ADR | — | $3.2M | <0.1% | SH 106,683 | 0001172661-26-003786 |